Crinetics Pharmaceuticals, Inc. Increase (Decrease) in Derivative Assets
Crinetics Pharmaceuticals, Inc. (CRNX) reported Increase (Decrease) in Derivative Assets of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeAssets · last filed 2024-02-28
- Crinetics Pharmaceuticals, Inc. increase (decrease) in derivative assets for fiscal 2023 was $0.00.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in derivative assets for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in derivative assets for fiscal 2021 was $68.00K.
| Period end | Increase (Decrease) in Derivative Assets 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-12-31 | $68.00K 10-K · filed 2024-02-28 |